Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Chun Cai

1PUBLICATIONS
9CO-AUTHORS
Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (1)

Sort by Publication Date:
|Dec 18, 2025
Anti-mitotic agent SB-216 overcomes taxane resistance in castration-resistant prostate cancer and exhibits anti-tumour efficacy in pancreatic cancer.

Rui Wang, Chun Cai, Shanshan Deng

Pageof 1

Frequent Collaborators

1 joint publications

Rui Wang

1 joint publications

Shanshan Deng

1 joint publications

Yang Xie

1 joint publications

Satyanarayana Pochampally

1 joint publications

David J Hamilton

1 joint publications

Bernd Meibohm

1 joint publications

Evan S Glazer

1 joint publications

Duane D Miller

1 joint publications

Wei Li

Frequent Collaborators

1 joint publications

Rui Wang

1 joint publications

Shanshan Deng

1 joint publications

Yang Xie

1 joint publications

Satyanarayana Pochampally

Top Related Videos

Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel
06:44

Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel

Published on : Sep 08, 2017

13.9K
See more related videos

Top Related Videos

Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel
06:44

Generation of Prostate Cancer Cell Models of Resistance to the Anti-mitotic Agent Docetaxel

Published on : Sep 08, 2017

13.9K
See more related videos